Crossref
Regulatory Provisions for Introducing Phytopharmaceutical Drugs in Indian Market
Pharmacognosy Reviews · 01.01.2027 · 21 (41) · 79-97
DOI: 10.5530/phrev.20270080 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacognosy Reviews, online erschienen am 01.01.2027. Verfasst von Anshita Anshita und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Anshita, A., Dalal, A., Yadav, G., & Nanda, A. (2027). Regulatory Provisions for Introducing Phytopharmaceutical Drugs in Indian Market. Pharmacognosy Reviews, 21(41), 79-97. https://doi.org/10.5530/phrev.20270080
Vancouver
Anshita A, Dalal A, Yadav G, Nanda A. Regulatory Provisions for Introducing Phytopharmaceutical Drugs in Indian Market. Pharmacognosy Reviews. 2027;21(41):79-97. doi:10.5530/phrev.20270080
BibTeX
@article{Anshita2027,
author = {Anshita, Anshita and Dalal, Anshu and Yadav, Gobind and Nanda, Arun},
title = {Regulatory Provisions for Introducing Phytopharmaceutical Drugs in Indian Market},
journal = {Pharmacognosy Reviews},
year = {2027},
volume = {21},
number = {41},
pages = {79--97},
doi = {10.5530/phrev.20270080}
}
EUVIMED